Dissertation > Excellent graduate degree dissertation topics show

The basic law of the breast cancer topo Ⅱ α expression and correlation with the efficacy of anthracycline

Author: RenWenXiao
Tutor: SongSanTai;JiangZeFei
School: PLA Military Academy of Medical Sciences
Course: Oncology
Keywords: topoisomerase IIα(topo IIα) breast cancer anthracycline chemotherapy immunohistochemistry(IHC)
CLC: R737.9
Type: Master's thesis
Year: 2007
Downloads: 78
Quote: 3
Read: Download Dissertation

Abstract


Breast cancer is the most common malignant disease of women. The mortality for breast cancer is the highest one in female,and being rise these years.It is a traditional topic to search the prognostic marker relevant to breast cancer treatment. Anthracycline is one of the most effective drug in breast cancer treatment,it can improve the patient’s therapeutic efficacy and overall survival.For the local efficacy and the adverse of anthracycline ,and to avoid over treatment,search an ideal molecular biologic marker that has predictive value for anthracycline is very necessary. The DNA topoisomerase IIα(topo IIα) is the effective target of many antitumor medicine including anthracycline.It is often associated with drug resistance when its level decrease.Our study considering the biological behaviour direct the breat cancer prognosis and treatment ,study the regular pattern of topo IIαexpression in breast cancer,analyze the correlation of topo IIαand anthracycline effect.Collecting clinical data of advanced patients who had received anthracycline in our department for analyze retrospectively. Tested 180 cases by immunohistochem istry(IHC) staining and judged the result by microscopic scoring. Compare the relationship between topo IIαexpression and anthracycline effect and clinicopathological marker by statistics analyze.First part:we analyzed the regularity of topo IIαexpression in breast cancer. The relatede biomarkers and topo IIαwere tested by immunohistochemical (IHC) procedures in operational paraffin-embedded tumor blocks and material tissue paraffin-embedded tumor blocks. The results showed that a high topo IIαpositive rate (52.2%)was significantly present in breast cancer. We found topo IIαexpression in breast cancer was not associated with any of the clinicopathological parameters such as age , menstruation status, histologic type, clinical TNM stage and metastasis site(P> 0.05),while it was associated with tumor size, axillary lymphonodus metastasis and metastasis site numbers(P<0.05). With regard to the other important biomarkers ,We didn’t found the correlation between ER、PR and the expression of topo IIα(P>0.05),but our study show the correlation with HER-2 (P<0.05) ,and HER-2 is coexpressed with topo IIα.We also analyzed some other biomarkers,as P53、MDR-1、Bcl—2、PCNA,but the statistics result show they are not associated with topo IIα(P>0.05).Second part:our study emphasized on the relationship between the clinical response to anthracycline and topo IIαin metastatic or locally advanced breast cancer patients.The result show the positive expression of topo IIαhad significant relativity with the clinical response of anthracycline and TTP(P<0.05).In addition,our study found topo IIαexpression have no correlation with disease-free survival (DFS) and overall survival (OS).

Related Dissertations

  1. The Effects of Pu-erh Tea on Prevetion and Treatment of Tumor,R285.5
  2. Study of Sepia Ink-Astragalus Preparation for Relieving Damage Caused by Chemotherapy,R285.5
  3. Yu Ren- Cun Academic Thought and clinical experience in the clinical observation of combination chemotherapy in advanced gastric cancer with Yiqihuoxuejiedu side,R249
  4. The Related Study of Breast-conserving Surgery Plus Postoperative Tangential Irradiation,R737.9
  5. The Relevance Research between Breast Cancer Calcification X Performance and Pathology,R737.9
  6. Inhibition of Conventional Chemotherapy Combined with Metronomic Chemotherapy on Breast Cancer Xenografts in Nude Mice,R737.9
  7. Comparative Analysis on CTF and CEF Regimens as Postoperative Adjuvant Chemotherapy in the Treatment of Phase Ⅱ Breast Cancer,R737.9
  8. Recurrent Ovarian Cancer Surgery Again with Surial Analysis of Relevant Factors,R737.31
  9. The Correlation of Ultrasound Elasticity with the Expressions of Estrogen Receptor, Progestron Receptor, C-erbB-2 in Breast Cancer,R445.1
  10. The Feasibility of the Immunohistochemistry Classification to Predicting Prognosis in Breast Cancer,R737.9
  11. The Experimental Study of Antiangiogenic and Induction of Apoptosis by Maximum Tolerated Dose Combined with Low-dose Cyclophosphamide in Breast Cancer,R737.9
  12. Maximum Tolerated Dose Combined with Metronomic Chemoterpy on Proliferation and Angiogenesis in Treatment of Breast Cancer,R737.9
  13. Analysis of Clinial and Patholgoic Characteristics between the Han and the Uygur Patients with Triple-negative Breast Cancer,R737.9
  14. Clinical Signifinance of Combined Detection of Tumor Markers in Breast Cancer,R737.9
  15. Effect of the Function of MRP1 on Human Lung Adenocarcinoma Chemotherapy Resistance,R734.2
  16. The Expression and Clinical Significance of Ercc1 in Human Gastric Cancer,R735.2
  17. Clinical Characteristics and Prognosis Analysis of Advanced Cholan Giocarcinoma,R735.8
  18. Clinical Study on Effect of Xie Shi Lung Cancer NO.2 in Malignant Pleural Effusion of Lung Cancer,R734.2
  19. Isoflavone intake and the risk of breast and prostate cancer Meta-analysis,R737.25
  20. Cancer patients before and after chemotherapy changes in blood glucose and glycosylated hemoglobin,R587.1
  21. Analysis of BRCA2 Coding Snps in Association with Breast Cancer Prognosis,R737.9

CLC: > Medicine, health > Oncology > Genitourinary tumors > Breast tumor
© 2012 www.DissertationTopic.Net  Mobile